<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-1UTX106O</identifier><date>2007</date><creator>Čufer, Tanja</creator><creator>Snoj Šarvari, Nataša</creator><relation>documents/doc/1/URN_NBN_SI_doc-1UTX106O_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-1UTX106O_001.txt</relation><format format_type="issue">1</format><format format_type="volume">11</format><format format_type="type">article</format><format format_type="extent">str. 72-76</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">499067</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-1UTX106O</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antibodies, monoclonal</subject><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="eng">Cancer vaccines</subject><subject language_type_id="eng">Cytokines</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="slv">karcinom</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Biološko in tarčno zdravljenje karcinomov</title></Record>